Bacterial Pathogens and Antibiotic Resistance in Bloodstream Infections in Tunisia: A 13-Year Trend Analysis.

The antimicrobial resistance (AMR) surveillance network has been monitoring bloodstream bacterial pathogens and their resistance since 1999 in Tunisia. We report the long-term trends in the distribution of bloodstream bacterial pathogens and their resistance patterns from this surveillance database. We analyzed antibiotic resistance rates in 11 tertiary teaching hospital laboratories under the AMR surveillance network during 2011-2023, focusing on six priority bacterial pathogens, using the Cochrane-Armitage test for trend analysis. Of 22,795 isolates, (38.5%) was the most common, followed by (20.4%), (13.6%), and (10.3%). Carbapenem resistance was highest in (77%), followed by (29.3%), (19.4%), and (6.8%). Carbapenem-resistant and third-generation cephalosporin-resistant (3GCREB) increased from 10.6% to 26.3% (-value < 0.001), and from 39% to 50.2%, respectively, during 2011-2023 (-value < 0.001). Vancomycin resistance (38.3%) and the emergence of linezolid resistance in 2019 (2.4%) were reported in isolates. Resistance to carbapenems and 3GC is a major challenge to controlling BSI in Tunisia. The national AMR surveillance network helps monitor annual patterns and guides empirical therapy. An integrated database combining clinical profiles and resistance data via real-time data-sharing platforms could improve clinical decision-making.